Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
lidocaine hydrochloride monohydrate, Quantity: 106.65 mg (Equivalent: lidocaine hydrochloride, Qty 100 mg)
Baxter Healthcare Pty Ltd
lidocaine (lignocaine) hydrochloride monohydrate
Injection, solution
Excipient Ingredients: sodium chloride; sodium hydroxide; hydrochloric acid; water for injections
Intravenous, Epidural, Infiltration
5 ampoules, 10 ampoules, 25 ampoules
(S4) Prescription Only Medicine
For production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. Treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest.
Visual Identification: Clear colourless or almost colourless solution; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 24 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Child resistant closure
Licence status A
2015-04-07
LIGNOCAINE-CLARIS _Lignocaine hydrochloride 1% and 2% Solution for injection _ _ _ _ _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions people ask about Lignocaine-Claris. It does not contain all the information that is known about Lignocaine-Claris. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor will have weighed the risks of you taking Ligocaine-Claris against the benefits they expect it will have for you. This medicine is likely to be used while you are at the clinic or in hospital. If possible, please read this leaflet carefully before this medicine is given to you. In some cases this leaflet may be given to you after the medicine has been used. IF YOU HAVE ANY CONCERNS ABOUT BEING GIVEN THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET. You may need to read it again. WHAT LIGNOCAINE-CLARIS IS USED FOR Lignocaine-Claris belongs to two groups of medicines known as local anaesthetics and antiarrhythmic drugs. Local anaesthetics stop pain and feeling in the area around where it is injected; and antiarrhythmic drugs work by restoring irregular and/or rapid heartbeats to normal. Lignocaine-Claris may be used for the management of other conditions that are not mentioned above. Your doctor will be able to tell you about the specific condition for which you have been prescribed Lignocaine-Claris. This medicine is available only with a doctor's prescription Ligocaine-Claris will not put you to sleep. Lignocaine-Claris is also used after surgery to relieve pain. It can also be used to make childbirth less painful. Depending on the amount used, Lignocaine-Claris will either totally stop pain or will cause a partial loss of feeling. Lignocaine hydrochloride is sometimes combined with adrenaline to make it last longer. Adrenaline makes the blood vessels at the site of injection narrower, which keeps the lignocaine hydrochloride where it is needed for a longer time. Lignocaine-Claris Baca dokumen lengkap
Lidocaine-Baxter (Lidocaine (Lignocaine) hydrochloride (as monohydrate)) Version 1.0 1 of 17 AUSTRALIAN PRODUCT INFORMATION LIDOCAINE-BAXTER (LIDOCAINE (LIGNOCAINE) HYDROCHLORIDE) SOLUTION FOR INJECTION 1 NAME OF THE MEDICINE Lidocaine (Lignocaine) hydrochloride (as monohydrate) 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Lidocaine (Lignocaine) hydrochloride (as monohydrate) 10 mg/mL or 20 mg/mL, solution for injection Lidocaine (Lignocaine) hydrochloride (as monohydrate) is a fast acting local anaesthetic and antiarrhythmic drug. Lidocaine-Baxter is a clear, colourless to almost colourless, sterile, isotonic, preservative-free solution containing Lidocaine (Lignocaine) hydrochloride (as monohydrate) 1% or 2%. For the full list of excipients, see Section 6.1 List of excipients. 3 PHARMACEUTICAL FORM Solution for Injection. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For production of local or regional anaesthesia by nerve block, infiltration injection, caudal or other epidural blocks. Treatment or prophylaxis of life-threatening ventricular arrhythmias, including those associated with myocardial infarction, general anaesthesia in patients predisposed to ventricular arrhythmias, digitalis intoxication, or following resuscitation from cardiac arrest. 4.2 DOSE AND METHOD OF ADMINISTRATION Lidocaine (Lignocaine) Injection is for one dose in one patient only. Discard any remaining contents. As a local anaesthetic for infiltration and nerve block The dosage varies and depends upon the area to be anaesthetised, vascularity of the tissues, number of neuronal segments to be blocked, individual tolerance and the technique of anaesthesia. The lowest dose needed to provide effective anaesthesia should be administered. For specific techniques and procedures, refer to standard textbooks. Lidocaine-Baxter (Lidocaine (Lignocaine) hydrochloride (as monohydrate)) Version 1.0 2 of 17 It is recommended that the dose of lidocaine (lignocaine) at any one time should not exceed 3mg/kg. However, the dose administered must be tailo Baca dokumen lengkap